Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.46 |
| ▸ | DRD1 | P21728 | 5/20 | 0.45 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP7 | P09237 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | PDCD1 | Q15116 | 1/20 | 0.40 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.40 |
| ▸ | DRD2 | P14416 | 1/20 | 0.39 |
| ▸ | DRD4 | P21917 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Benzaldehyde SCHEMBL432383 | 0.88 | ALDH1A1 (0.61) | ALDH1A1CYP2A6DRD1ALDH1A3TYR | |
| SCHEMBL5733969 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL6032 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| Benzene SCHEMBL28288569 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL10969109 | 0.82 | ALDH1A1 (0.68) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| Fluoride SCHEMBL28127101 | 0.80 | ALDH1A1 (0.65) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| Methane SCHEMBL28723228 | 0.80 | ALDH1A1 (0.65) | ALDH1A1CYP2A6DRD1DRD2DRD4 | |
| SCHEMBL10804430 | 0.79 | CYP2A6 (0.67) | ALDH1A1CYP2A6DRD1ALDH1A3TYR | |
| Tannin Pyrogallol SCHEMBL28663913 | 0.77 | ALDH1A1 (0.78) | ALDH1A1CYP2A6DRD1MMP3CYP1A2 | |
| 4-Hydroxybenzaldehyde SCHEMBL8727208 | 0.77 | ALDH5A1 (0.64) | ALDH1A1CYP2A6ALDH1A3TYRMMP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8569490-B2 | Intermediate and process for preparing entecavir using same | HANMI SCIENCE CO., LTD (KR) | 2013-10-29 | — | — | US | claimed |
| EP-2382217-B1 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI SCIENCE CO LTD (KR) | 2013-10-23 | — | — | EP | claimed |
| EP-2382217-A2 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | Hanmi Holdings Co., Ltd. (KR) | 2011-11-02 | — | — | EP | claimed |
| US-20110251387-A1 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI HOLDINGS CO., LTD. (KR) | 2011-10-13 | — | — | US | claimed |
| WO-2010074534-A2 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI PHARM. CO., LTD. (KR) | 2010-07-01 | — | — | WO | claimed |
| US-8569490-B2 | Intermediate and process for preparing entecavir using same | HANMI SCIENCE CO., LTD (KR) | 2013-10-29 | — | — | US | disclosed |
| EP-2382217-B1 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI SCIENCE CO LTD (KR) | 2013-10-23 | — | — | EP | disclosed |
| EP-2382217-A2 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | Hanmi Holdings Co., Ltd. (KR) | 2011-11-02 | — | — | EP | disclosed |
| US-20110251387-A1 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI HOLDINGS CO., LTD. (KR) | 2011-10-13 | — | — | US | disclosed |
| WO-2010074534-A2 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | HANMI PHARM. CO., LTD. (KR) | 2010-07-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110251387-A1 | NOVEL INTERMEDIATE AND PROCESS FOR PREPARING ENTECAVIR USING SAME | ENTPD5, ENTPD1, SAMHD1 | ALDH1A1 589/4885CYP2A6 465/4885DRD1 1062/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.